This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

CECity And Pennsylvania Collaborative Partners Win URAC Gold Quality Improvement Award

Stocks in this article: RAD

PITTSBURGH, Oct. 16, 2012 /PRNewswire/ -- CECity and the Pennsylvania Collaborative, a strategic consortium that includes Highmark Blue Cross Blue Shield, Rite Aid Corporation, the Pharmacy Quality Alliance (PQA), Gateway Health Plan, and the University of Pittsburgh-School of Pharmacy, have received URAC's prestigious Gold Award for Best Practices in Health Care Consumer Empowerment and Protection.  This top honor in the category of Health Information/Decision Support recognizes health care management programs that demonstrate quality improvement in the health care delivered to consumers. 

The program, titled "ASPIRE (Advancing Safety and Performance Improvement for Pharmacy Excellence): Integrating Quality Metrics with Focused Interventions to Improve Adherence," leveraged CECity's innovative social cloud-based platform to successfully, and cost-effectively, scale and spread continuous quality improvement as measured by PQA's medication adherence measures, for Rite Aid pharmacies, providers, and patients across Pennsylvania. 

Through CECity, multiple health plans were able to contribute data, which was merged to generate a single performance profile for each pharmacy, complete with identification of that pharmacy's critical performance gaps. A single " How Do I Improve" button then dynamically linked each provider to their own personalized pathway for learning and improvement, which included recommended organizational, professional, and patient-centered tools that were continuously evaluated across the wide geographic network to measure their effectiveness in closing the gaps.

"The Pennsylvania Collaborative serves as a perfect example of how health plans and community-based pharmacy providers can collaborate to improve medication adherence at an individual and population level," said David Nau, Senior Director at PQA. "PQA looks forward to continuing our collaboration with CECity to bring the power of this technology to pharmacies and health plan partners across the country as we work to enhance patient value."

"We would like to thank URAC for this wonderful honor, and applaud our partners in the Pennsylvania Collaborative for their leadership and shared vision in creating a continuous learning health system model for improvement," said Annette Boyer, RPh, Vice President at CECity.  "By combining our cloud platform and this proven model for provider engagement, we are now able to rapidly scale quality initiatives. This includes EQuIPP® (the Electronic Quality Improvement Platform for Plans and Pharmacies), the nations' pharmacy quality improvement benchmarking service, and MedConcert®, the first platform to meaningfully connect all stakeholders, including physicians and other health care providers, hospitals, pharmacies, health plans, and their patients, to support ongoing performance improvement, lifelong learning, and enterprise-wide care coordination."

Key results of the ASPIRE program included successfully "moving the needle" on the PQA chronic disease adherence measures, which are used for the CMS Medicare Advantage Plan Star Ratings, aggregating system-wide performance measurement across multiple health plans, and measuring the impact of focused and community-generated interventions on performance. The ability to engage providers in quality improvement, rapid cycle learning, and clinical communities across wide geographic regions was also demonstrated.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs